Scientists at the Weizmann Institute of Science in Israel have developed a new minimally invasive therapy with STEBA Biotech that could change the game for low-risk prostate cancer patients in future. The drug they’ve developed, known as Tookad, is the first therapy to offer a focal cure in prostate cancer, meaning it seeks to target … Continue reading Promising New Treatment for Prostate Cancer in 2017